Results 1 to 10 of about 4,607,099 (394)

Prescription drug monitoring programs [PDF]

open access: yesThe Nurse Practitioner, 2015
To help combat prescription drug misuse, most states have implemented Prescription Drug Monitoring Programs (PDMPs)-electronic databases that collect and track prescription data and flag suspected diversion activities. Equipped with expanding prescriptive authority, NPs are now poised to become vital change agents in expanding the potential ...
Anthony J. Gudoski
semanticscholar   +5 more sources

Prescription drug spending by payer: Implications for managed care [PDF]

open access: yesExploratory Research in Clinical and Social Pharmacy
Background: Brand-name prescription drugs are an important driver of prescription drug spending, but different payers may bear these costs differentially necessitating different policy goals for each payer.
Yousef Chavehpour   +2 more
doaj   +2 more sources

Serotonin syndrome in a patient with chronic pain taking analgesic drugs mistaken for psychogenic nonepileptic seizure: a case report [PDF]

open access: yesYeungnam University Journal of Medicine, 2021
Serotonin syndrome (SS) is a potentially life-threatening condition that is caused by the administration of drugs that increase serotonergic activity in the central nervous system. We report a case of serotonin syndrome in a patient with chronic pain who
Mathieu Boudier-Revéret   +1 more
doaj   +1 more source

Mandatory Use of Prescription Drug Monitoring Programs

open access: greenJournal of the American Medical Association (JAMA), 2015
Rebecca L. Haffajee   +2 more
openalex   +2 more sources

Prescribed stimulant medications: Trends in the last decade, pre and post COVID-19 response

open access: yesExploratory Research in Clinical and Social Pharmacy, 2023
Background: Recent studies indicate that COVID-19 has had a significant impact on access and continuity to opioid and benzodiazepine medications; little is known about its effect on access to and utilization of stimulant medications.
Meelee L. Kim   +4 more
doaj   +1 more source

Patient-based benefit-risk assessment of medicines: development, refinement, and validation of a content search strategy to retrieve relevant studies

open access: yesJournal of the Medical Library Association, 2021
Introduction: Poor indexing and inconsistent use of terms and keywords may prevent efficient retrieval of studies on the patient-based benefit-risk assessment (BRA) of medicines.
Hiba El Masri   +5 more
doaj   +1 more source

Drugs associated with cataract formation represent an unmet need in cataract research

open access: yesFrontiers in Medicine, 2022
Decreased light transmittance through the ocular lens, termed cataract, is a leading cause of low vision and blindness worldwide. Cataract causes significantly decreased quality of life, particularly in the elderly.
Jack Carlson   +4 more
doaj   +1 more source

Blockchain-Based Processing of Health Insurance Claims for Prescription Drugs

open access: yesIEEE Access, 2022
The current legacy system used in processing health insurance claims causes a huge amount of financial loss every year due to fraud claims. It is also highly prone to privacy and security threats due to the use of traditional methods.
Aysha Alnuaimi   +5 more
doaj   +1 more source

Supramolecular assemblies based on natural small molecules: Union would be effective

open access: yesMaterials Today Bio, 2022
Natural products have been used to prevent and treat human diseases for thousands of years, especially the extensive natural small molecules (NSMs) such as terpenoids, steroids and glycosides.
Yong Hou   +8 more
doaj   +1 more source

Combination of Merocel sponge with Lipopolysaccharide to establish rat rhinosinusitis model

open access: yesBrazilian Journal of Otorhinolaryngology, 2023
Objective: The study aimed to investigate the feasibility of establishing rhinosinusitis model in rats combinated with Lipopolysaccharide (LPS) and merocel sponge.
Mengmeng Sun   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy